BACKGROUND: Understanding preclinical transitions to impairment in cognitive abilities associated with risks for functional difficulty and dementia. This study characterized in the Women's Health and Aging Study (WHAS) II 9-year declines and transitions to impairment across domains of cognition. METHODS: The WHAS II is an observational study of initially high-functioning, community-dwelling women aged 70-80 years at baseline. Random-effects models jointly compared rates of decline, and discrete-time Cox models estimated hierarchies of incident clinical impairment on measures of psychomotor speed and executive function (EF) using the Trail Making Test and in immediate and delayed verbal recall using the Hopkins Verbal Learning Test. Patterns of transition were related to incidence of global cognitive impairment on the Mini-Mental State Exam (MMSE). RESULTS: Mean decline and impairment occurred first in EF and preceded declines in memory by about 3 years. Thereafter, memory decline was equivalent to that for EF. Over 9 years, 49% developed domain-specific impairments. Risk of incident EF impairment occurred in 37% of the sample and was often the first impairment observed (23.7%), at triple the rate for psychomotor speed (p < .01). Risk of immediate and delayed recall impairments was nearly double that for psychomotor speed (p values <.01). Incident impairment in EF and delayed recall was associated with greater risk for MMSE impairment. CONCLUSIONS: Executive dysfunction developed first among nearly one quarter of older women and was associated with elevated risk for global cognitive impairment. Because EF declines preceded memory declines and are important to efficient storage and retrieval EF represents an important target for interventions to prevent declines in memory and MMSE both of which are associated with progression to dementia.
BACKGROUND: Understanding preclinical transitions to impairment in cognitive abilities associated with risks for functional difficulty and dementia. This study characterized in the Women's Health and Aging Study (WHAS) II 9-year declines and transitions to impairment across domains of cognition. METHODS: The WHAS II is an observational study of initially high-functioning, community-dwelling women aged 70-80 years at baseline. Random-effects models jointly compared rates of decline, and discrete-time Cox models estimated hierarchies of incident clinical impairment on measures of psychomotor speed and executive function (EF) using the Trail Making Test and in immediate and delayed verbal recall using the Hopkins Verbal Learning Test. Patterns of transition were related to incidence of global cognitive impairment on the Mini-Mental State Exam (MMSE). RESULTS: Mean decline and impairment occurred first in EF and preceded declines in memory by about 3 years. Thereafter, memory decline was equivalent to that for EF. Over 9 years, 49% developed domain-specific impairments. Risk of incident EF impairment occurred in 37% of the sample and was often the first impairment observed (23.7%), at triple the rate for psychomotor speed (p < .01). Risk of immediate and delayed recall impairments was nearly double that for psychomotor speed (p values <.01). Incident impairment in EF and delayed recall was associated with greater risk for MMSE impairment. CONCLUSIONS: Executive dysfunction developed first among nearly one quarter of older women and was associated with elevated risk for global cognitive impairment. Because EF declines preceded memory declines and are important to efficient storage and retrieval EF represents an important target for interventions to prevent declines in memory and MMSE both of which are associated with progression to dementia.
Authors: Robert S Wilson; Carlos F Mendes De Leon; Lisa L Barnes; Julie A Schneider; Julia L Bienias; Denis A Evans; David A Bennett Journal: JAMA Date: 2002-02-13 Impact factor: 56.272
Authors: Oscar L Lopez; William J Jagust; Corinne Dulberg; James T Becker; Steven T DeKosky; Annette Fitzpatrick; John Breitner; Constantine Lyketsos; Beverly Jones; Claudia Kawas; Michelle Carlson; Lewis H Kuller Journal: Arch Neurol Date: 2003-10
Authors: Robert S Wilson; Laurel A Beckett; Lisa L Barnes; Julie A Schneider; Julie Bach; Denis A Evans; David A Bennett Journal: Psychol Aging Date: 2002-06
Authors: Ellen L McGough; Valerie E Kelly; Rebecca G Logsdon; Susan M McCurry; Barbara B Cochrane; Joyce M Engel; Linda Teri Journal: Phys Ther Date: 2011-05-26
Authors: George W Rebok; Karlene Ball; Lin T Guey; Richard N Jones; Hae-Young Kim; Jonathan W King; Michael Marsiske; John N Morris; Sharon L Tennstedt; Frederick W Unverzagt; Sherry L Willis Journal: J Am Geriatr Soc Date: 2014-01-13 Impact factor: 5.562
Authors: Alden L Gross; Qian-Li Xue; Karen Bandeen-Roche; Linda P Fried; Ravi Varadhan; Mara A McAdams-DeMarco; Jeremy Walston; Michelle C Carlson Journal: J Gerontol A Biol Sci Med Sci Date: 2016-04-15 Impact factor: 6.053
Authors: N L Watson; C Rosano; R M Boudreau; E M Simonsick; L Ferrucci; K Sutton-Tyrrell; S E Hardy; H H Atkinson; K Yaffe; S Satterfield; T B Harris; A B Newman Journal: J Gerontol A Biol Sci Med Sci Date: 2010-06-25 Impact factor: 6.053
Authors: Yi-Fang Chuang; Dana Eldreth; Kirk I Erickson; Vijay Varma; Gregory Harris; Linda P Fried; George W Rebok; Elizabeth K Tanner; Michelle C Carlson Journal: Neurobiol Aging Date: 2013-12-18 Impact factor: 4.673
Authors: Michelle C Carlson; Kirk I Erickson; Arthur F Kramer; Michelle W Voss; Natalie Bolea; Michelle Mielke; Sylvia McGill; George W Rebok; Teresa Seeman; Linda P Fried Journal: J Gerontol A Biol Sci Med Sci Date: 2009-08-19 Impact factor: 6.053